Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

Share Price is delayed by 15 minutes
Get Live Data
2,259.00    57.00 (2.59%)
Bid:
2,244.00
Ask:
2,246.00
Spread: 2.00 (0.089%)
Market Cap: £22.82b
III Live PriceLast checked at - London Stock Exchange

Intraday 3i Group Share Chart

Directorate Change

13 May 2021 07:00

RNS Number : 4435Y
3i Group PLC
13 May 2021
 

 

3i Group plc: non-executive Director appointment

 

Peter McKellar

3i Group plc announces the appointment of Peter McKellar as a non-executive Director with effect from 1 June 2021.

 

Peter McKellar was until September 2020 Global Head of Private Markets at Standard Life Aberdeen plc and had previously led Standard Life Investments' private equity and infrastructure business and been their Chief Investment Officer. He joined Standard Life Investments in 1999. Prior to that he held a variety of finance posts in industry and corporate finance positions.

 

Peter McKellar is Deputy Chairman of AssetCo plc and is also a Board Member of Scottish Enterprise, Scotland's national economic development agency.

 

Simon Thompson, 3i Chairman, said: "We are pleased to announce Peter's appointment to 3i's Board. Peter brings great experience and understanding of the asset management industry with a particular expertise in private equity and infrastructure."

 

Peter commented: "I am very pleased to be joining 3i as the Company continues to execute its strategic plan. 3i has a varied and resilient portfolio, a strong institutional franchise, and is well placed to continue to generate superior returns for its shareholders."

 

There are no further matters to be disclosed in accordance with paragraph 9.6.13R of the UKLA's Listing Rules.

 

 

-Ends-

 

For further information, contact:

Kathryn van der Kroft 020 7975 3021

Communications Director

 

Silvia Santoro 020 7975 3258

Investor Relations Director

 

Notes to Editors:

 

About 3i

 

3i is a leading international investment manager focused on mid-market private equity and infrastructure. Its core investment markets are northern Europe and North America. For further information, please visit: www.3i.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAATMFTMTBBBLB
Date   Source Headline
9th Mar 20188:30 amRNSAction refinancing and Capital Markets seminar
28th Feb 20183:44 pmRNSTotal Voting Rights
28th Feb 20183:44 pmRNSDirector/PDMR Shareholding
1st Feb 20183:51 pmRNSDirector/PDMR Shareholding
1st Feb 20187:00 amRNSFY2018 Q3 performance update
31st Jan 20184:17 pmRNSTotal Voting Rights
31st Jan 20184:16 pmRNSDirector/PDMR Shareholding
2nd Jan 20184:15 pmRNSPortfolio Update
19th Dec 20173:18 pmRNSTotal Voting Rights
19th Dec 20173:15 pmRNSDirector/PDMR Shareholding
12th Dec 20173:05 pmRNSBlock listing Interim Review
6th Dec 201711:13 amRNSDirector/PDMR Shareholding
5th Dec 201712:00 pmRNSDirector/PDMR Shareholding
4th Dec 201710:32 amRNSDirector Declaration
30th Nov 20173:29 pmRNSTotal Voting Rights
30th Nov 20173:28 pmRNSDirector/PDMR Shareholding
16th Nov 201712:19 pmRNSDoc re. Half Yearly Report 2017
16th Nov 20177:00 amRNS3i Group Half-year results to 30 September 2017
31st Oct 20173:54 pmRNSDirector/PDMR Shareholding
31st Oct 20173:53 pmRNSTotal Voting Rights
3rd Oct 201712:37 pmRNSPortfolio Update
29th Sep 20173:51 pmRNSTotal Voting Rights
29th Sep 20173:50 pmRNSDirector/PDMR Shareholding
18th Sep 20178:30 amRNSPrivate Equity Capital Markets Seminar
31st Aug 20173:48 pmRNSTotal Voting Rights
31st Aug 20173:46 pmRNSDirector/PDMR Shareholding
31st Jul 20174:41 pmRNSTotal Voting Rights
31st Jul 20174:36 pmRNSDirector/PDMR Shareholding
28th Jul 20174:12 pmRNSDirector/PDMR Shareholding
26th Jul 20173:14 pmRNSDirector/PDMR Shareholding
26th Jul 20177:00 amRNSQ1 Performance update
6th Jul 20173:24 pmRNSPortfolio Update
30th Jun 20174:28 pmRNSDirector/PDMR Shareholding
30th Jun 20173:18 pmRNSTotal Voting Rights
30th Jun 20173:17 pmRNSDirector/PDMR Shareholding
29th Jun 20172:54 pmRNSResult of AGM
29th Jun 20172:35 pmRNSDoc re. AGM Resolutions
29th Jun 20172:25 pmRNSDirector/PDMR Shareholding
19th Jun 20174:19 pmRNSDTR 6.3.5
13th Jun 201711:26 amRNSDirector/PDMR Shareholding
12th Jun 20174:48 pmRNSBlock listing Interim Review
2nd Jun 201711:16 amRNSDirector/PDMR Shareholding
31st May 20174:25 pmRNSTotal Voting Rights
31st May 20174:21 pmRNSDirector/PDMR Shareholding
31st May 201710:12 amRNSDoc re. 2017 Annual Report and Accounts
30th May 20178:30 amRNSPrivate Equity Capital Markets Seminar
18th May 20172:49 pmRNSDirector/PDMR Shareholding
18th May 20179:41 amRNSDirector/PDMR Shareholding
18th May 20177:00 amRNSResults for the year to 31 March 2017
28th Apr 20173:05 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.